Promena mentalnog statusa izazvana moksifloksacinom
Moxifloxacin-induced Mental Status Change
Sažetak
Moxifloxacin is an antibiotic used orally or parenterally in the emergency department (ED) for the treatment of various infections especially acute exacerbation of chronic bronchitis and community-acquired pneumonia. The side effects of the drug are mainly on the gastrointestinal system and central nervous system side effects are rare. Here, we present an elderly patient had altered mental status associated with the use of moxifloxacin. Upon discontinuation of the drug, the patient quickly returned to baseline neurologic status. In the evaluation of altered mental status in elderly patients in the ED, much of the effort should be spent primarily on ruling out more complex diagnoses. However, this approach requires more invasive and advance testing. To considering drug side effects among these more complicated diagnoses may increase non-invasive and radiation-free options for the patient and physician.
Reference
References:
1. Douros A, Grabowski K, Stahlmann R. Safety issues and drug-drug interactions with commonly used quinolones. Expert Opin Drug Metab Toxicol 2015;11:25–39.
2. AVELOX® 400 mg film-coated tablet [Last accessed on 2021 December]. Available from: https://www.rxlist.com/avelox-drug.htm#description.
3. Faizan Mazhar, Shahzad Akram, and Nafis Haider. Moxifloxacin-induced acute psychosis: A case report with literature review. J Res Pharm Pract 2016;5(4):294–296.
4. Fish DN. Fluoroquinolone adverse effects and drug interactions. Pharmacotherapy 2001;21(10 Pt 2):253S–72S.
5. Stahlmann R, Lode H. Safety considerations of fluoroquinolones in the elderly: An update. Drugs Aging 2010;27:193–209.
6. Carbon C. Comparison of side effects of levofloxacin versus other fluoroquinolones. Chemotherapy 2001;47(Suppl 3):9–14.
7. Elbe DH, Chang SW. Moxifloxacin-warfarin interaction: A series of five case reports. Ann Pharmacother 2005;39:361–4.
8. Tasleem H, Viswanathan R. Moxifloxacin-induced delirium with hallucinations. Psychosomatics 2011;52:472–4.
9. Pedrós A, Emilio Gómez J, Angel Navarro L, Tomás A. Levofloxacin and acute confusional syndrome Med Clin (Barc) 2002;119:38–9.
10. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.